Barbara Gayle Duncan - Jun 14, 2023 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
Director
Signature
/s/Maria Stahl as Attorney-in-Fact for Barbara Duncan
Stock symbol
FUSN
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/14/2023, 05:06 PM
Previous filing
May 9, 2023
Next filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Opion (Right to Buy) Award $0 +17K $0.00 17K Jun 14, 2023 Common Stock 17K $4.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option fully vests on the earlier of (i) June 14, 2024 or (ii) the 2024 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.